Neurosurgery Perioperative Orders & Functional Case Checklist

A medical-student orientation guide to common post-op neurosurgery workflows, ICU/TBI checklists, and functional neurosurgery handoffs.

Use checkboxes to mark items reviewed. Checked items represent common default considerations; unchecked items are optional or situation-dependent. This page is an educational orientation tool, not a clinical order set or institutional protocol. Medication doses and workflows must always be verified with the supervising team, local policy, pharmacy guidance, patient weight, renal/hepatic function, allergies, and clinical context.
1. Post-Op Craniotomy

Use immediately after craniotomy, burr hole, CSF shunt, or stereotactic procedures. Most components default-on; titrate vitals/neuro-check frequency to acuity.

Patient Care / Monitoring

ComponentDose / Route / FreqDetails / Notes
Vital SignsRoutineQ15min × 1 hr → Q30min × 1 hr → Q1H
Vital Signs (after +2 hr)Q1HTransition order
Neuro ChecksQ15min × 1 hr → Q30min × 1 hr → Q1HMirror VS cadence
Neuro Checks (after +2 hr)Q1H
Check Procedural SiteQ15min × 1 hr → Q30min × 1 hr → Q1H × 4 hr → Q4HSurgical wound / drain site
Height & WeightONCEFor weight-based dosing
Convert IV to saline lockONCEWhen tolerating PO
Urinary CatheterIndwellingRemove POD#1 AM if possible
Intake & OutputQ1H
D/C Urinary CatheterONCE — AM POD#1SCIP / CAUTI prevention
Nurse CommunicationDo not remove urinary catheter if UOP <30 mL/hr
Dysphagia ScreenONCEBefore any PO
Notify Provider of UOPIf UOP >250 mL/hr × 3 consecutive hours (DI surveillance)

Activity / Positioning

ComponentDose / Route / FreqDetails / Notes
ActivityBed restAdvance per surgeon
Position PatientConstantHOB elevated 30°
Turn & RepositionQ2HPressure injury prevention

Diet / IV Fluids

ComponentDose / Route / FreqDetails / Notes
NPONPO except for medications until cleared
DietRegular (when cleared)Advance after dysphagia screen
0.9% NaCl1,000 mL IV @ 80 mL/hrDefault maintenance — avoid hypotonic in TBI
Lactated Ringers1,000 mL IV @ 80 mL/hrAlternative isotonic

Medications — Symptomatic

ComponentDose / Route / FreqDetails / Notes
Acetaminophen650 mg PO Q4H PRNFever >38.4 °C / mild pain / HA
Ondansetron4 mg IV push Q6H PRNNausea / vomiting

Pain — Mild

ComponentDose / Route / FreqDetails / Notes
Acetaminophen650 mg PO Q6H PRNMild pain / headache

Pain — Moderate (select ONE)

ComponentDose / Route / FreqDetails / Notes
Oxycodone IR5 mg PO Q4H PRN × 7 d
Acetaminophen-oxycodone 325/51 tab PO Q4H PRN × 7 dWatch APAP ceiling
Tramadol50 mg PO Q6H PRN × 7 dCaution: ↓ seizure threshold — avoid in seizure-prone post-craniotomy

Pain — Severe (select ONE)

ComponentDose / Route / FreqDetails / Notes
Oxycodone IR10 mg PO Q4H PRN × 7 d
Acetaminophen-oxycodone 325/52 tabs PO Q6H PRN × 7 d

Antihypertensives

ComponentDose / Route / FreqDetails / Notes
Labetalol10 mg IV push Q15min PRNSBP >goal; hold HR <55 / bronchospasm
Hydralazine10 mg IV push Q4H PRNGive if SBP not at goal after 2 doses labetalol
Nicardipine drip0.2 mg/mL, start 5 mg/hr, max 15 mg/hrTitrate by 1–2.5 mg/hr Q10–15 min

GI Prophylaxis / Bowel Regimen

ComponentDose / Route / FreqDetails / Notes
Famotidine20 mg IV push BIDStress ulcer ppx if indicated
Pantoprazole40 mg IV dailyAlternative
Docusate100 mg PO BIDHold for loose stools
Senna8.6 mg PO QHSHold for loose stools
Bisacodyl10 mg PR daily PRNConstipation rescue

Other

ComponentDose / Route / FreqDetails / Notes
Dexamethasone4 mg IV QIDTumor / vasogenic edema; taper per plan
Insulin SC sliding scaleGlucose management
SCIP Neurosurgery Post-Op Antibiotics+1 minSee subphase below

Perioperative Antibiotic Prophylaxis Logic

Risk-stratify before selecting and dosing:
  • MRSA risk: prior MRSA, chronic wound care, dialysis, transfer from inpatient stay >3 d
  • High SSI risk: obesity, malnutrition, CSF leak, EVD, spinal instrumentation, age >60, open posterior approach, OR time >2–4 h, prior shunt infection, emergent case, ASA ≥2, DM
For teaching: clean cranial/device cases usually use peri-incision prophylaxis with intra-op redosing when indicated and discontinuation within 24 h unless infection is being treated. Exact agent and dose should follow local antimicrobial guidance.
ScenarioTypical prophylaxis conceptStudent pearl
Low SSI risk, no major allergyCefazolin is the usual first-line concept for elective craniotomy, CSF shunting, and many implant procedures; dosing is weight-based.Do not anchor on a fixed adult dose. Timing and redosing are as important as agent choice.
Severe beta-lactam allergyClindamycin or vancomycin-type alternatives may be used depending on local guidance and organism risk.Clarify the allergy phenotype; many “penicillin allergies” are not true contraindications to cefazolin.
MRSA riskVancomycin may be added or substituted when MRSA risk is meaningful; start early enough for infusion before incision.Vancomycin is not a casual add-on. It changes timing, stewardship, and nephrotoxicity considerations.
High SSI / gram-negative riskBroader coverage is a surgeon/pharmacy/infectious-disease decision guided by procedure type, local microbiology, and patient risk.A student should ask why coverage is broader, not memorize a fixed ceftriaxone or fluoroquinolone default.

Post-Op Imaging & Labs

ComponentDose / Route / FreqDetails / Notes
XR Chest 1 ViewToday, portableFollow-up opacities / line check
XR ShuntogramUrgent, portableVP shunt cases
CT Brain w/o contrastSTATRoutine post-op brain
MRI Brain w/o contrastUrgentTumor — known mass s/p surgery
MRI Brain w/ + w/o contrastUrgentPreferred for tumor extent of resection
BMPAM LabDefault daily
CBC w/ diffAM Lab
CMP, Mg, Phos, Prealbumin, PT/INR, aPTTT+1;0200, AM LabAdd as clinically indicated

Respiratory & Consults

ComponentDose / Route / FreqDetails / Notes
Oxygen therapyNasal cannula 2 LTitrate to SpO₂ >92%
Bedside Swallow EvalEDD tomorrowIf dysphagia screen FAILED
OT Eval & TreatmentRoutine
PT Eval & TreatmentRoutine
Social Work / Case ManagementDisposition planning
2. ICU Admission

Generic critical care admission shell — overlay specialty subphase (Neuro ICU, post-op, etc.).

Admit / Code Status / Prophylaxis

ComponentDose / Route / FreqDetails / Notes
Full ResuscitationConstantDefault unless DNAR
DNARSelect order sentence if applicable
Present on Admission (POA)Documentation flag
VTE ProphylaxisMechanical + pharmacologic per risk

Patient Care / Monitoring

ComponentDose / Route / FreqDetails / Notes
Vital SignsRoutineICU continuous + Q1H documentation
Neuro ChecksQ2HNeuro ICU patients
Spine ChecksQ1HSpinal cord injury / post-spine
Vital Sign ParametersMAP >65Customize per pathology
Urinary CatheterIndwellingStrict I&O
Intake & OutputQ2H
Arterial Line PressureQ1HContinuous monitoring
Hemodynamic MonitoringQ1H
Central Venous PressureQ4H
Enteral TubeNG, suction (gravity)
Tobacco Treatment CounselingUse when relevant to admission and discharge planning
Rapid Response / Critical Care Team ActivationConstantUse local escalation pathway for deterioration

Vasoactive Drips

ComponentDose / Route / FreqDetails / Notes
Norepinephrine 16 mcg/mLStart 5, max 20 mcg/minGoal MAP; titrate Q5–15 min by 1–5 mcg/min. First-line vasopressor.
Epinephrine 20 mcg/mLStart 2, max 10 mcg/minAdd for refractory shock / cardiogenic
Vasopressin 1 unit/mL0.04 units/min fixedAdjunct to NE in septic shock
Phenylephrine 200 mcg/mLStart 50, max 350 mcg/minPure α — useful in tachyarrhythmia

Continuous IV Antihypertensives

ComponentDose / Route / FreqDetails / Notes
Nicardipine 0.2 mg/mLStart 5, max 15 mg/hrPreferred for SAH/ICH BP control
Esmolol 10 mg/mLStart 50, max 300 mcg/kg/min
Nitroglycerin 200 mcg/mLStart 5, max 200 mcg/minGoal SBP

Stress Ulcer Prophylaxis — Indications

Order PPI/H2 only if ≥1 indication present:
  • Coagulopathy (PLT <50K, INR >1.5, or PTT >2× ULN)
  • Mechanical ventilation
  • Trauma — spinal cord injury or severe TBI
  • Burn / thermal injury
  • Steroid use (>250 mg hydrocortisone equivalent/day)
  • Active PUD / GERD / pre-admission PPI
ComponentDose / Route / FreqDetails / Notes
Famotidine20 mg IV push BIDFirst-line
Pantoprazole40 mg IV dailyPPI alternative

Bowel & Glucose

ComponentDose / Route / FreqDetails / Notes
Docusate100 mg via FT BID
Senna8.8 mg via FT BID
Bisacodyl10 mg PR daily PRNConstipation
Insulin SC sliding scaleGlycemic control
Insulin (non-DKA continuous infusion)If persistent hyperglycemia

Labs

Labs Now (STAT): ABG, BMP, Ca, CBC w/ diff, CMP, CPK, D-dimer, fibrinogen, lactic acid, hepatic panel, Mg, aPTT, Phos, PT/INR, resuscitation panel arterial, troponin I.

Labs in AM (T+1;0200): Same panel + prealbumin.

Microbiology, Imaging & Cardiac

ComponentDose / Route / FreqDetails / Notes
Blood cultures × 2Q15min × 2 sitesBEFORE first abx dose
Urinalysis w/ reflex cultureRoutine
Respiratory cultureIf pneumonia suspected
XR Chest 1 viewUrgent, portableDyspnea / line placement
XR NG tube verificationToday, portableConfirm gastric placement
CT Brain w/o contrastUrgent, portableAMS / r/o bleed
CT Abd/Pelvis w/ PO + IV contrastSTATAbdominal pain
EKG 12-leadRoutine, ONCE
EKG series × 3STAT → +6 hr → +12 hrSerial troponin / dysrhythmia rule-out

Respiratory, Therapies & Consults

ComponentDose / Route / FreqDetails / Notes
Incentive SpirometryRoutine
Oxygen therapyNC 2 LTitrate SpO₂ >92%
PT / OT / SLP evalEarly mobilization
Social Work / Case Management
Nutrition consult
Wound care (enterostomal)
Palliative CareGoals-of-care conversations
3. TBI / Intermediate Head Injury

Step-down or floor-level TBI orders. Escalate to Neuro ICU subphase if GCS deteriorates, ICP monitoring needed, or hemodynamic instability.

Patient Care

ComponentDose / Route / FreqDetails / Notes
Vital SignsQ2HRoutine
Neuro ChecksQ2H↑ frequency to Q1H if GCS change
Nurse CommunicationDo NOT remove c-collar until c-spine cleared by team
Notify ProviderSigns/symptoms of neurologic decompensation
Pneumatic Compression Device (SCDs)Below knee, bilateral, BIDMechanical VTE ppx
Intake & OutputQ4H
VTE ProphylaxisPharmacologic — see A&P note
Care Plan: Cerebral Perfusion RiskUse when neurologic monitoring and escalation triggers need to be explicit

Weight Bearing Status

Order per affected extremity (LUE/RUE/LLE/RLE):

  • Non-weight bearing
  • Partial weight bearing
  • Toe-touch weight bearing (LE only)
  • Weight bearing as tolerated (WBAT)

Activity / Positioning

ComponentDose / Route / FreqDetails / Notes
ActivityOut of bed with assistanceConstant order
Position PatientHOB ≥30°Cerebral venous drainage
Turn & RepositionQ2HWhile in bed

Diet / IV Fluids

ComponentDose / Route / FreqDetails / Notes
NPOUntil dysphagia screen passed
DietRegular, regular consistencyModified by nutrition alert if applicable
0.9% NaCl1,000 mL IV @ 80 mL/hrIsotonic — AVOID hypotonic in TBI
0.9% NaCl + KCl 20 mEq/L1,000 mL IV @ 100 mL/hr
Isolyte S pH 7.4 bolus500 mL IV bolus ONCEBalanced crystalloid

Seizure Prophylaxis (Levetiracetam)

Early post-traumatic seizure prophylaxis is commonly considered for severe TBI during the first 7 days. Brain Trauma Foundation guidance does not establish levetiracetam as superior to phenytoin, so agent and dose should follow local neurotrauma practice.

Renal function, age, frailty, weight, and mental status should change how any antiseizure-medication default is interpreted.
ComponentDose / Route / FreqDetails / Notes
Levetiracetam IV/PO/FTInstitution-specific, often BIDCommonly used because it is easy to administer and has fewer interactions; adjust for renal function and patient factors.
Alternative antiseizure agentPer neurotrauma / epilepsy teamPhenytoin/fosphenytoin or other agents may be selected depending on indication, interactions, and monitoring needs.
Stop date / reassessmentUsually day 7 if prophylaxis onlyContinuing beyond 7 days should have a documented reason, such as seizure, cortical irritation concern, or epilepsy history.

Analgesia

Sedating opioids obscure the neuro exam. Prefer acetaminophen-first strategies and the lowest effective opioid dose when needed. Avoid tramadol when seizure risk is meaningful.

Antipyretic / Mild Pain

ComponentDose / Route / FreqDetails / Notes
Acetaminophen650 mg via FT Q4H PRNFever T >38.4 °C
Acetaminophen650 mg via FT Q4H PRNMild pain / headache

Pain — Moderate (select ONE)

ComponentDose / Route / FreqDetails / Notes
Oxycodone IR5 mg liquid via FT Q4H PRN × 7 d
Morphine2 mg IV Q4H PRN × 7 d
Hydromorphone0.2 mg IV Q4H PRN × 7 d

Pain — Severe (select ONE)

ComponentDose / Route / FreqDetails / Notes
Oxycodone IR10 mg liquid via FT Q4H PRN × 7 d
Morphine4 mg IV Q4H PRN × 7 d
Hydromorphone0.5 mg IV Q4H PRN × 7 d
Fentanyl25 mcg IV Q4H PRN × 7 dHemodynamically neutral
Fentanyl (rescue)50 mcg IV push Q2H PRNIf no oral access or inadequate response

GI Prophylaxis & Bowel Regimen

ComponentDose / Route / FreqDetails / Notes
FamotidineInstitution-specificStress ulcer prophylaxis if severe TBI/ICU risk factor is present
PantoprazoleInstitution-specificAlternative when PPI is specifically indicated
Docusate100 mg PO BIDHold for loose stools
Senna8.6 mg PO QHSHold for loose stools
Bisacodyl10 mg PR every other day PRNConstipation

Antiemetic / Antihypertensive

ComponentDose / Route / FreqDetails / Notes
Ondansetron4 mg IV push Q6H PRNN/V
Hydralazine10 mg IV push Q6H PRNSBP >goal; give over 2 min
Labetalol10 mg IV push Q15min PRNSBP above goal; give over 2 min

Labs & Imaging

ComponentDose / Route / FreqDetails / Notes
CBC w/ diffAM Lab
BMPAM LabDefault daily
CMP, Mg, Phos, Prealbumin, PT/INR, aPTTT+1;0200, AM LabAdd per indication
CT Brain w/o contrastUrgent — cerebral hemorrhage suspectedRepeat for exam change / per protocol

Consults

ComponentDose / Route / FreqDetails / Notes
Occupational Therapy Eval & TreatmentRoutine
Physical Therapy Eval & TreatmentRoutine
Neuropsychology consultCognitive baseline
Speech-Language PathologyDysphagia / cognitive-linguistic
Social Work / Case Management
Health Care Proxy DesignationMedico-legal
4. Quick A&P Template — TBI / Intermediate Head Injury

Educational structure for how a TBI/head-injury plan is commonly organized. Adapt to the patient, service preferences, and supervising resident/attending.

  • Q4H neuro checks
  • Blood pressure goal per neurosurgery team, commonly SBP <140 after cranial surgery/head injury
  • Seizure prophylaxis if indicated, with dose adjusted to patient factors
  • Antibiotics only if prophylaxis window or infection indication applies
  • PT / OT
  • DVT prophylaxis: SCDs ± pharmacologic prophylaxis per team and imaging stability
  • Keep HOB > 30°
  • Diet: Regular (pending dysphagia screen)
  • Code status: Full
What is SCIP?

SCIP = Surgical Care Improvement Project — a CMS / Joint Commission national quality initiative (launched 2006) aimed at reducing surgical complications, especially SSIs, VTE, and perioperative cardiac events.

Antibiotic prophylaxis measures

  • Prophylactic abx given within 1 hour before incision (2 hours for vanc / fluoroquinolones)
  • Correct agent selected for the procedure
  • Prophylactic antibiotics discontinued within 24 hours of anesthesia-end time for most procedures unless there is documented infection or a procedure-specific reason to extend.

Other historical SCIP measures

  • Hair removal with clippers, not razors
  • Perioperative normothermia
  • Perioperative glucose control (cardiac surgery)
  • Beta-blocker continuation
  • VTE prophylaxis ordered + given within 24 h of surgery
Many SCIP measures were retired from public reporting once compliance plateaued, but the workflow logic remains useful for trainees: antibiotic selection, timing before incision, and discontinuation within the expected prophylaxis window unless infection is being treated.
5. Neuromodulation Program — DBS, SCS, Pumps & Hardware

This section is designed for students learning what to anticipate before and after common functional neurosurgery cases. The goal is not to memorize an order set; it is to understand the handoff logic, device-specific hazards, and the questions that should be asked before the patient leaves the perioperative area.

Device safety frame: medication holds, antibiotics, imaging sequence, device interrogation, MRI compatibility, and anticoagulation plans are program-specific. Always confirm with the neurosurgery, movement disorders, anesthesia, pain, and device teams before acting.

Pre-Operative STN DBS Checklist

Checklist itemTypical student-facing wordingWhy it matters
NPO / dietNPO at midnight; morning medications only if specifically allowed with a sip of water.Standard anesthesia safety while preserving critical medications when approved.
Parkinson medicationsOrder home Parkinson medications, but hold dopaminergic medications after midnight for awake STN DBS unless the team says otherwise.Patients are often intentionally tested in the OFF-medication state for targeting and stimulation assessment.
Morning PD doseHave the patient bring the morning Parkinson medication dose to the perioperative area in a labeled bag, but do not take it pre-op unless instructed.Medication may be needed immediately after lead placement or if the plan changes.
Blood pressure medicationsContinue approved BP medications the morning of surgery with a sip of water.Hypertension during lead placement increases hemorrhage concern; hypotension also impairs testing.
Antiplatelets / anticoagulantsConfirm aspirin, antiplatelets, anticoagulants, and supplements have been held per protocol.Lead-pass hemorrhage is a catastrophic complication; this is a pre-op timeout item.
Skin prepChlorhexidine shampoo/wash the night before or morning of surgery if part of local workflow.Hardware procedures are infection-sensitive.
MRI workflowIf pre-op stereotactic MRI is planned, send the patient to MRI rather than directly to the OR; avoid IV pumps or non-compatible equipment in the MRI pathway.The morning workflow may depend on imaging before frame/lead placement.
MRI-compatible gownConfirm gown and transport equipment do not contain metallic clips or MRI-incompatible hardware.Small workflow misses can delay the case or create MRI safety risk.
Antibiotic planCheck allergy status and confirm peri-incision antibiotic selection with anesthesia/nursing.Antibiotics must match allergy/MRSA risk and be timed before incision.
Baseline examDocument tremor, rigidity, speech, gait baseline, and last dopaminergic dose time.Baseline symptoms guide intraoperative testing and post-op interpretation.

Post-Operative STN DBS Checklist

Checklist itemCommon patternWhy it matters
DietSips, then diet as tolerated after swallow/nausea assessment.Many patients are older, sedated, or nauseated after frame-based surgery.
Vitals / neuro checksFrequent early checks, often Q1H for several hours, then space if stable.Early hemorrhage, seizure, confusion, or lead-related deficits must be caught quickly.
Home medicationsRestart regular medications; Parkinson medications usually resume on the pre-op schedule unless the functional team changes it.Avoid dopamine-withdrawal syndromes and severe OFF-state immobility.
AntibioticsPerioperative cefazolin or alternative by allergy/MRSA risk, typically limited to 24 hours unless infection is suspected.Hardware infection prevention without unnecessary prolonged prophylaxis.
Post-op CTNoncontrast CT head with stereotactic/lead-localization protocol as requested by the surgeon.Assesses hemorrhage, pneumocephalus, and electrode location.
Wound careKeep cranial wounds covered and dry; reinforce but do not remove dressings unless instructed.Reduces contamination and avoids disturbing fresh incisions.
Discharge teachingKeep wounds dry for about 10 days, no strenuous activity for about 6 weeks, call for fever, drainage, wound redness, new neurologic deficit, or severe headache.Simple discharge rules catch the main early complications.
Programming follow-upReturn to DBS clinic for initial stimulation programming, commonly around 4-6 weeks depending on local practice.Leads are usually implanted before the system is optimized therapeutically.

Post-Operative Functional Craniotomy / Epilepsy Resection Checklist

Checklist itemCommon patternWhy it matters
Diet / activitySips then diet as tolerated after swallow/nausea assessment; activity as tolerated when cleared.Early mobility helps recovery, but sedation, seizures, neglect, weakness, or visual field deficits can create fall risk.
Vitals / neuro checksFrequent checks early, then space if stable.Watch for hemorrhage, edema, seizure, aphasia, weakness, visual field cut, neglect, or mental-status change.
Seizure planContinue home antiseizure medications; confirm peri-op loading, rescue medication, and when to call neurology/epilepsy.Medication omission is a common and preventable post-op seizure trigger.
Steroid / edema planDexamethasone taper only if indicated by surgeon/pathology/edema risk; pair with glucose and GI-risk awareness.Dominant temporal/frontal resections and tumor-adjacent epilepsy cases may have edema-related deficits.
Lines / Foley / compressionRemove arterial line, Foley, and calf compressors once mobilizing and clinically appropriate.Reduces line/catheter complications while preserving early safety.
Morning labsCBC and electrolytes as directed; sodium is especially relevant if there is DI/SIADH risk or major sellar/hypothalamic involvement.Checks blood loss and physiology; electrolyte shifts can worsen seizures or mental status.
Blood pressureMaintain surgeon-specified SBP goal, commonly below 140; labetalol/hydralazine/nicardipine are typical tools.Post-craniotomy hypertension increases bleeding risk, while over-treatment can impair cerebral perfusion.
Pain / nauseaAcetaminophen-first, low-dose opioids PRN, ondansetron or similar antiemetic per local medication guidance.Excess sedation can obscure the neurologic exam and complicate seizure monitoring.
Wound / dressingKeep cranial wound covered and dry; reinforce but do not remove dressings unless instructed.Protects incision and helps patients recognize abnormal drainage.
Discharge teachingKeep wound dry as instructed, remove sutures/staples per plan, no strenuous activity for about 6 weeks, and follow seizure/driving restrictions.Students should explicitly know the red flags: fever, drainage, severe headache, new deficit, seizure cluster, or confusion.

SCS Trial / Permanent Implant Checklist

Checklist itemCommon patternWhy it matters
Pre-op anticoagulation reviewConfirm anticoagulants, antiplatelets, and NSAIDs were held according to neuraxial/device policy.Epidural hematoma is rare but devastating.
AntibioticsCefazolin or alternative based on allergy/MRSA risk before incision; duration per local device policy.Implanted pulse generators and leads are infection-sensitive.
Trial lead precautionsKeep dressing dry/intact; avoid bending, twisting, lifting, or lead-tension movements.Lead migration can ruin trial interpretability.
Paddle lead precautionsFocused lower-extremity motor/sensory exam, wound checks, log-roll or spine precautions if directed.Early neurologic change after laminotomy needs immediate attention.
Device representativeConfirm interrogation/programming and documentation before discharge.A technically successful implant still needs functional programming.
Discharge restrictionsNo driving while on opioids or until cleared; avoid strenuous bending/twisting/lifting during early healing.Protects lead position and wound closure.

IPG / Battery Change Checklist

Checklist itemCommon patternWhy it matters
Device identityConfirm device type, laterality, generator location, baseline settings, and reason for replacement.Wrong-device or wrong-side errors are preventable with a deliberate timeout.
Antibiotic / allergy checkConfirm prophylaxis and allergy/MRSA status.Generator pockets can seed the whole system.
Anticoagulation planConfirm peri-op hold/resume timing with surgeon and prescribing clinician.Pocket hematoma increases pain, reoperation, and infection risk.
Post-exchange interrogationDocument impedance check, settings restored/updated, patient controller paired, and charging instructions if rechargeable.The case is not complete until therapy is confirmed.
Wound teachingKeep incision dry, avoid pressure over pocket, call for redness, drainage, fever, swelling, or sudden loss of benefit.Pocket infection and lead/system malfunction often present after discharge.

Intrathecal Baclofen Pump Emergencies

High-risk recognition item: suspected baclofen withdrawal or overdose is an emergency. Students should escalate immediately to neurosurgery/pain pump specialists, ICU/anesthesia, pharmacy, and the device team.
ScenarioCluesInitial management priorities
Withdrawal / underdoseReturn of baseline spasticity, pruritus, paresthesias, hypotension, fever, altered mental status; severe cases can progress to rigidity, rhabdomyolysis, organ failure, and a sepsis/malignant-hyperthermia-like picture.ABCs, ICU-level monitoring, urgent pump interrogation/refill status/catheter evaluation, contact the treating pump clinician. Restore intrathecal baclofen delivery when possible. Oral/enteral baclofen and IV benzodiazepines may be used as bridge therapy, but oral baclofen alone should not be relied on for severe withdrawal.
OverdoseDrowsiness, dizziness, somnolence, hypotonia, respiratory depression, hypothermia, seizures, loss of consciousness, coma.ABCs, airway/ventilatory support as needed, urgent pump specialist involvement. The pump reservoir may need to be emptied/stopped by trained personnel; CSF aspiration is a specialist procedure in selected severe cases.
Common triggersEmpty reservoir, missed refill, programming error, pump alarm, catheter kink/disconnection, pocket fill, infection, recent refill or concentration change.Ask: When was the last refill? What is the current concentration/daily dose? Any pump alarms? Any recent MRI? Any trauma or new wound problem?

Neuromodulation Hardware Infection — First Steps

SituationWhat to look forFirst-step mindset
Superficial cellulitis concernLocalized erythema, tenderness, warmth, drainage absent or minimal, no exposed hardware, patient clinically stable.Photograph/mark borders, notify implanting team, check vitals and labs as directed. Antibiotics may be appropriate, but avoid delaying surgical evaluation.
Deep pocket/lead infection concernPurulence, wound dehiscence, fluctuance, exposed hardware, erosion, fever, bacteremia, severe pocket pain, recurrent drainage.Escalate urgently. Obtain cultures when feasible before antibiotics if stable; if septic or unstable, treat immediately. Deep or exposed hardware often requires washout and partial or complete explantation plus antibiotics.
DBS-specific hazardScalp erosion or lead exposure may seed intracranial hardware even if the patient looks well.Do not dismiss a small scalp opening. Keep covered, avoid manipulation, and contact functional neurosurgery promptly.
SCS / pump-specific hazardGenerator or pump pocket infection can track along tunneled leads/catheters.Assess the entire hardware path, not just the painful pocket.
6. Anesthesia Considerations — Neuromodulation & Functional Cases

Pre-op huddle prompts and agent considerations for DBS, SCS, intrathecal pump, RFA/rhizotomy, and VNS. Built around what actually affects intraoperative neurophysiology and surgical conditions — not generic GA checklists.

DBS — Awake with Microelectrode Recording (MER)

The most anesthesia-sensitive functional case. Almost every common sedative degrades MER signal quality and the clinical exam.

Agents — what to use and what to avoid

AgentUse?Why
Dexmedetomidine✓ Preferred sedativePreserves STN/GPi firing patterns at low doses. Keep ≤0.3–0.5 mcg/kg/hr during MER. Higher doses still degrade burst patterns and can blunt tremor.
Remifentanil✓ Low-dose infusion OKFor pin placement and incision. Short context-sensitive half-time allows rapid wake-up for testing. Watch respiratory depression in elderly PD.
Propofol✗ STOP ≥20 min before MERSuppresses STN bursting pattern even at sub-sedative doses. Acceptable for burr hole drilling if fully off before recording starts.
Benzodiazepines✗ Avoid entirelySuppress STN neuronal firing for hours. Long half-life makes intraop testing unreliable. No pre-op midazolam.
Volatile agents✗ Not applicable (awake)
Neuromuscular blockade✗ NeverNeed to assess rigidity, tremor, and stimulation-induced motor effects.
Local anesthetic✓ GenerousPin site infiltration + scalp block (supraorbital, supratrochlear, auriculotemporal, greater/lesser occipital). This is where patient comfort is won or lost.

Hemodynamics

  • SBP target <140 mmHg from skin incision through final lead placement — every 10 mmHg above baseline increases ICH risk along the lead track.
  • Treat hypertension early and aggressively. Have labetalol and nicardipine drip drawn up before incision.
  • Avoid hypotension too — cerebral hypoperfusion in elderly PD patients triggers confusion that ruins testing.
  • Vasopressor preference: phenylephrine bolus over ephedrine (avoid tachycardia and tremor exacerbation in PD).

Patient prep

  • Hold PD meds 12 h pre-op for STN targeting — need patient in OFF state for tremor/rigidity assessment. Confirm with movement disorders neurologist.
  • Hold anticoagulants/antiplatelets per standard cranial protocol (ASA 7 d, clopidogrel 7 d, warfarin INR <1.3, DOACs 48–72 h).
  • Foley placed after frame on, before draping — long case + dex diuresis = full bladder = ruined exam.
  • Position: semi-sitting with frame fixed to table. VAE risk — precordial Doppler if available, T-piece on CVL, vigilant ETCO₂ monitoring.
  • Temperature: warming blanket on lower body only, avoid covering arms (need to see tremor).
  • Skip N₂O if any pneumocephalus expected.

DBS — Asleep (Image-Guided, No MER)

iCT or iMRI verification, no intraop testing. Anesthetic flexibility is much greater.

  • Standard GA acceptable — TIVA or volatile.
  • Same SBP <140 target during lead pass.
  • NMB acceptable since no motor testing.
  • If doing macrostimulation testing under light anesthesia: switch to TIVA + dex 30 min before testing window, hold NMB, communicate the "test window" timeline to anesthesia.
  • Pre-op PD meds can be continued (no exam needed) — confirm with movement disorders.

DBS — Asleep with MER (rare hybrid)

  • TIVA preferred: low-dose propofol (≤75 mcg/kg/min) + remifentanil + dex (≤0.3 mcg/kg/hr).
  • If volatile is unavoidable, keep sevoflurane <0.3 MAC (some centers tolerate up to 0.5 MAC but recording quality drops measurably above 0.3). Desflurane and isoflurane suppress MER more than sevo at equivalent MAC — avoid if possible.
  • NMB only for intubation, then allow full reversal before recording.
  • Recognize MER quality will be inferior to awake — adjust expectations and physiology mapping interpretation accordingly.

SCS — Trial (Percutaneous)

  • Local + light MAC: fentanyl 25–50 mcg, ± versed 1–2 mg titrated.
  • Patient must be responsive for paresthesia mapping — they need to report coverage of pain area as leads are advanced.
  • No NMB. No deep sedation.
  • Prone positioning — confirm airway access plan with anesthesia.

SCS — Permanent Paddle Lead (Laminotomy)

  • GA with IONM — SSEPs and EMG to confirm midline placement and avoid cord injury.
  • TIVA preferred (propofol + remifentanil ± low-dose ketamine) for stable SSEP signals. Volatile agents >0.5 MAC degrade SSEPs.
  • NMB ONLY for intubation — full reversal required before stimulation testing or EMG monitoring.
  • Confirm IONM tech is booked in pre-op huddle. Most common reason cases get delayed.
  • Some surgeons wake patient briefly intraop for paresthesia confirmation — flag this to anesthesia in advance so they plan emergence.

Intrathecal Drug Delivery (Pump Implant / Revision)

  • GA or spinal acceptable — spinal often preferred to avoid post-op nausea and allow dose titration awake.
  • If intraop test bolus given: respiratory monitoring × 24 h post-op (capnography preferred), naloxone at bedside.
  • Watch for CSF leak intraop — communicate to anesthesia for positioning and post-op flat bed orders.
  • Avoid IM opioids post-op — confounds intrathecal dose assessment.

Percutaneous Rhizotomy / RFA for Trigeminal Neuralgia

  • MAC with deep boluses for the noxious portions (foramen ovale cannulation, lesioning) and rapid emergence for sensory testing.
  • Typical pattern: propofol bolus 30–50 mg for cannulation → wake for sensory mapping → bolus for thermocoagulation → wake for re-test.
  • Anesthesia must be comfortable with repeated deep-light cycling. Discuss timing in pre-op huddle.
  • Watch for trigeminocardiac reflex — bradycardia/asystole on cannulation. Glycopyrrolate pre-treatment, atropine drawn up.
  • Airway: nasal cannula with ETCO₂, no NMB, no LMA (interferes with V3 access).

SRS (Gamma Knife / LINAC) — Sedation for Frame Placement

  • Local anesthetic infiltration at pin sites is the workhorse — generous lidocaine + bupivacaine mix.
  • Light sedation only: fentanyl 25–50 mcg ± midazolam 1 mg. Patient must protect airway and cooperate.
  • Anxiolysis is the main need — many patients tolerate frame placement with versed alone.
  • For pediatric or claustrophobic adults: consider GA with LMA for the imaging/treatment portion (rare in adult practice).

VNS Implant

  • Standard GA, neck extension positioning.
  • No NMB after intubation if intraop device interrogation/lead test planned (need to see vocal cord/diaphragm response).
  • Watch for bradycardia/asystole during initial lead test — atropine drawn up, communicate test timing to anesthesia.

Pre-Op Huddle — Questions to Ask Anesthesia

Use this as a pre-op huddle scaffold. The value is not the exact wording; it is making sure anesthesia, neurosurgery, nursing, and device support agree on the critical moments before incision.

For every case

  • What's our BP target during the critical phase, and what agents do you have ready to treat HTN?
  • What's the planned vasopressor of choice if hypotension occurs? Phenylephrine is often useful in PD/elderly patients because it avoids tachycardia and tremor exacerbation.
  • Are anticoagulants and antiplatelets confirmed held per protocol?
  • Are we avoiding N₂O?
  • What's the post-op disposition — ICU, step-down, or PACU-to-floor?

DBS with MER

  • What's your TIVA recipe for the MER window? Confirm: no propofol within 20 min of recording, no benzos at all, dex ≤0.5 mcg/kg/hr.
  • Are PD meds confirmed held since last night?
  • Scalp block plan — supraorbital, supratrochlear, auriculotemporal, occipital. Want me to do it or you?
  • VAE monitoring — precordial Doppler available? CVL aspiration plan?
  • Foley before drape?
  • What's the plan if patient becomes uncooperative or panicky mid-case? (Convert to dex bolus, abort and switch to asleep, etc.)

SCS paddle / spinal IONM cases

  • IONM tech confirmed and in room?
  • TIVA with propofol + remi, volatile <0.5 MAC?
  • NMB fully reversed before SSEP baseline?
  • Are we planning a brief wake-up for paresthesia mapping?

RFA / Rhizotomy

  • Comfortable with deep-light cycling for cannulation → testing → lesioning → testing?
  • Glycopyrrolate given? Atropine drawn up for trigeminocardiac reflex?
  • ETCO₂ via nasal cannula in place?

Pump / intrathecal

  • Test bolus planned — respiratory monitoring orders for 24 h post-op confirmed?
  • Naloxone at bedside in PACU and floor?

Quick Drug Reference — Functional OR

DrugTypical UsePearls
Dexmedetomidine0.2–0.5 mcg/kg/hr (no bolus)Sedative of choice for awake DBS. Bolus causes hypertension then hypotension — skip the load.
Remifentanil0.02–0.05 mcg/kg/minFor incision/pin pain. Off 5 min before testing window.
Propofol25–75 mcg/kg/min TIVAOff ≥20 min before MER. OK for asleep cases.
Phenylephrine50–100 mcg IV bolus PRNFirst-line pressor in awake DBS.
Labetalol5–10 mg IV PRNHTN control during lead pass.
Nicardipine drip2.5–15 mg/hrSustained HTN control.
Glycopyrrolate0.2 mg IV pre-opProphylaxis for trigeminocardiac reflex in rhizotomy.
Atropine0.5–1 mg IV bolusDrawn up for VNS lead test and rhizotomy. Treat bradycardia/asystole.
7. Safety Defaults and Teaching Pearls

General Safety Principles

  • High-frequency, low-risk items are usually easy to anticipate: vitals, neuro checks, SCDs, HOB ≥30°, acetaminophen, ondansetron, and bowel regimen.
  • High-risk items should always trigger deliberate review: opioids, anticoagulants, steroids, antibiotics, insulin, pressors, and sedatives.
  • Pain ladders should avoid duplicate opioid pathways; students should notice when more than one PRN opioid could be given for the same pain score.
  • Seizure prophylaxis, antibiotic prophylaxis, and stress-ulcer prophylaxis are best understood as indication-based decisions, not automatic medications.
  • Age, frailty, weight, renal function, hepatic function, and baseline cognition should change how medication defaults are interpreted.

Functional / Pain Neuromodulation Pearls

  • DBS Post-Op Day 0: frequent early vitals/neuro checks, no anticoagulation until cleared, prompt post-op CT or MRI per surgeon/device protocol, BP goal defined by the team, and a deliberate plan for restarting dopaminergic medications.
  • SCS Trial / Permanent Implant: peri-incision antibiotics by local prophylaxis guidance, neuraxial anticoagulation precautions, focused lower-extremity motor/sensory exam, wound check, activity restrictions, and device interrogation/programming before discharge.
  • Intrathecal Pump: bowel/bladder check, respiratory monitoring when intrathecal opioid dosing is involved, naloxone availability when appropriate, pump interrogation, and explicit withdrawal/overdose return precautions.

Radiosurgery-Specific Pearls

  • GK / LINAC SRS day-of: steroid, antiemetic, and anxiolytic plans are indication-specific; frame-pin care if a Leksell frame is used; post-procedure observation and neuro checks per local discharge criteria.
  • Post-SRS for trigeminal neuralgia: continue current neuropathic regimen, document baseline BNI pain score, schedule 3-month follow-up with imaging.

Safety Defaults Worth Remembering

  • Default mechanical VTE ppx (SCDs) on every neuro admission; require active opt-out with reason.
  • Default "Notify provider for UOP >250 mL/hr × 3 hrs" on every cranial post-op (DI surveillance).
  • Default "Notify provider for any GCS drop ≥2 points or new focal deficit" on all neuro admissions.
  • Default isotonic fluids only (NS or LR) on TBI/SAH/post-craniotomy sets — block hypotonic at order-entry.
  • Hyperosmolar therapy should be treated as an escalation pathway, not a routine floor order: central-line requirements, sodium/osmolality monitoring, renal status, and ICU-level oversight matter.

Documentation Habits

  • Document the neurologic baseline clearly before sedating medications, transfer, or discharge.
  • For device cases, document device type, laterality, target/lead level, generator site, interrogation status, and any programming changes.
  • For ICU patients, document the reason for ICU-level care, neurologic monitoring frequency, BP/MAP goals, airway status, and escalation triggers.
  • For SRS-related peri-procedure care, document baseline cranial nerve/pain score when relevant, steroid plan, frame or mask details, and follow-up imaging plan.
Selected Online Resources & Source Links

These links are intended as starting points for students who want to understand the source logic behind the checklist. For patient care, use local protocols and supervising-team guidance.

ResourceBest useLink
NACC infection prevention and managementNeuromodulation hardware infection prevention, antibiotic logic, and management framework.PubMed: NACC infection recommendations
NACC bleeding and coagulationAnticoagulation/antiplatelet decision-making for neuromodulation procedures.PubMed: NACC bleeding/coagulation recommendations
NACC cervical neurostimulationBest-practice framework for higher-risk cervical SCS/DRG-style anatomy.PubMed: NACC cervical neurostimulation
SCS patient selection and trial stimulation consensusHow to think about SCS candidacy, trialing, psychosocial screening, and expected benefit.PMC full text: SCS selection/trial consensus
ASRA antithrombotic guidelinesNeuraxial/regional anesthesia anticoagulation framework; useful when thinking about SCS and epidural access.ASRA fifth edition guideline
Brain Trauma Foundation severe TBI guidelinesSeizure prophylaxis, VTE prophylaxis, ICP/CPP, hyperosmolar therapy, and severe TBI ICU principles.Brain Trauma Foundation guidelines
ASHP/IDSA/SIS/SHEA surgical antimicrobial prophylaxisAgent selection, timing, weight-based dosing, and redosing principles for surgical prophylaxis.IDSA guideline page
Intrathecal baclofen withdrawal safety informationRecognition of baclofen underdose/withdrawal and why urgent pump-specialist escalation matters.Lioresal withdrawal safety page
Intrathecal baclofen emergency proceduresFDA-label emergency framework for overdose and withdrawal/underdose.FDA label / refill kit PDF
DBS overview for patientsPatient-facing overview of DBS indications, risks, and workflow.AANS DBS overview
DBS hardware infection outcomesClinical outcomes by management strategy: medical therapy, retention, partial removal, or complete explantation.DBS infection management experience